New cancer warnings added to eczema creams

Eczema creams sold by Novartis AG and Astellas Pharma Inc. will come with a “black-box” warning about a possible risk of cancer from the prescription treatments, U.S. regulators said on Thursday.

A black-box warning is the strongest type used in the United States for prescription drugs.

The new warnings apply to Novartis AG’s drug Elidel and Astellas Pharma’s Protopic.

Print Version
Tell-a-Friend

RELATED ARTICLES:

Obesity, lack of exercise reported in asthmatics   Research Findings in Allergen Immunotherapy Unveiled   Efficacy, Dosage Concerns Unresolved on Sublingual Immunotherapy   Probiotic for babies doesn’t ward off allergies   Doctors warn of rash from mobile phone use   Fish in children’s diet cuts eczema risk: study   Guide helps doctors manage vaccine allergies   Asthma monitoring on the Web   Students with food allergies often not prepared   Special infant formulas cut long-term allergy risk   Mediterranean diet in pregnancy may curb allergies   Aspirin may help prevent asthma in women